This infomration is significant today but it will be useless once the label is expanded. Once the label is expanded, Vascepa will be the only drug for Triglycerides < 500. An insurance company will not allowed to have prior authorizations that require you to try generic Lovaza or Niacin or Fenefibrates first. It will be easy for physicians or patients or Amarin to stop this from occurring.
Market Data 
Markets 
AI
